AGREEMENTIntellectual Property Assignment Agreement • March 8th, 2022 • Biolargo, Inc. • Chemicals & allied products • Indiana
THIS AGREEMENT (“Agreement”) is made and entered into as of this 1st day of March, 2022 (the “Effective Date”), by and between Clyra Medical Technologies, Inc., a California corporation (“Clyra”), BioLargo, Inc., a Delaware corporation (“BioLargo”), Scion Solutions, LLC, an Indiana limited liability company (“Scion”), the undersigned members of Scion (“Scion Members”), and for the limited purposes set forth below, Douglas Morgan, Andrew Filler, and Steven Harrison (collectively, the “Clyra/BioLargo Agents”).
AGREEMENTAgreement • March 8th, 2022 • Biolargo, Inc. • Chemicals & allied products • California
THIS AGREEMENT (“Agreement”) is made and entered into as of this 3rd day of March, 2022, by and between Clyra Medical Technologies, Inc., a California corporation (“Clyra”), and BioLargo, Inc., a Delaware corporation (“BioLargo”), with respect to the following:
